Urapidil HCl

CAS# 64887-14-5

Urapidil HCl

Catalog No. BCC5044----Order now to get a substantial discount!

Product Name & Size Price Stock
Urapidil HCl: 5mg $12 In Stock
Urapidil HCl: 10mg Please Inquire In Stock
Urapidil HCl: 20mg Please Inquire Please Inquire
Urapidil HCl: 50mg Please Inquire Please Inquire
Urapidil HCl: 100mg Please Inquire Please Inquire
Urapidil HCl: 200mg Please Inquire Please Inquire
Urapidil HCl: 500mg Please Inquire Please Inquire
Urapidil HCl: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of Urapidil HCl

Number of papers citing our products

Chemical structure

Urapidil HCl

3D structure

Chemical Properties of Urapidil HCl

Cas No. 64887-14-5 SDF Download SDF
PubChem ID 167980 Appearance Powder
Formula C20H30ClN5O3 M.Wt 423.94
Type of Compound N/A Storage Desiccate at -20°C
Solubility Soluble to 50 mM in water
Chemical Name 6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethylpyrimidine-2,4-dione;hydrochloride
SMILES CN1C(=CC(=O)N(C1=O)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC.Cl
Standard InChIKey KTMLZVUAXJERAT-UHFFFAOYSA-N
Standard InChI InChI=1S/C20H29N5O3.ClH/c1-22-18(15-19(26)23(2)20(22)27)21-9-6-10-24-11-13-25(14-12-24)16-7-4-5-8-17(16)28-3;/h4-5,7-8,15,21H,6,9-14H2,1-3H3;1H
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of Urapidil HCl

Descriptionα1-adrenoceptor antagonist and 5-HT1A receptor agonist (pIC50 values are 6.13 and 6.4 respectively). Clinically used hypotensive agent.

Urapidil HCl Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Urapidil HCl Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Urapidil HCl

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.3588 mL 11.7941 mL 23.5882 mL 47.1765 mL 58.9706 mL
5 mM 0.4718 mL 2.3588 mL 4.7176 mL 9.4353 mL 11.7941 mL
10 mM 0.2359 mL 1.1794 mL 2.3588 mL 4.7176 mL 5.8971 mL
50 mM 0.0472 mL 0.2359 mL 0.4718 mL 0.9435 mL 1.1794 mL
100 mM 0.0236 mL 0.1179 mL 0.2359 mL 0.4718 mL 0.5897 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on Urapidil HCl

Urapidil HCl is an α1-adrenoceptor antagonist and 5-HT1A receptor agonist.

Featured Products
New Products
 

References on Urapidil HCl

[Effects of urapidil and cimetidine on wedged hepatic venous pressure and systemic hemodynamics in cirrhotic patients with portal hypertension].[Pubmed:12828169]

Zhonghua Wai Ke Za Zhi. 2000 Apr;38(4):287-90.

OBJECTIVE: To compare the effects of urapidil and cimetidine on portal pressure and systemic hemodynamics. METHODS: We observed the effects of urapidil (Urapidil HCl, n = 15), cimetidine (n = 20) and placebo (0.9% sodium chloride, n = 10) on wedged hepatic venous pressure (WHVP), hepatic venous pressure gradient (HVPG), and systemic hemodynamics. RESULTS: Urapidil at a dosage of 25 mg intravenously reduced WHVP from 33.33 +/- 7.85 cm H2O to 23.75 +/- 6.83 cm H2O, the average value was 28.75% +/- 9.81% (P > 0.01); and HVPG from 21.92 +/- 2.34 cm H2O to 14.07 +/- 3.57 cm H2O, the average value was 35.81% +/- 8.71% (P < 0.01). The free hepatic venous pressure (FHVP) however was not changed significantly (P > 0.05). The heart rate was increased from 70 +/- 13 BPM to 79 +/- 21 BPM (P < 0.05), and the systolic blood pressure and the diastolic blood pressure were reduced from 122 +/- 40 mm Hg to 95 +/- 32 mm Hg and 75 +/- 17 mm Hg to 55 +/- 15 mm Hg respectively (P < 0.01). After cimetidine administered at a dosage of 400 mg intravenously, WHVP and HVPG were reduced from 34.25 +/- 7.34 cm H2O to 29.05 +/- 7.03 cm H2O and 23.14 +- 8.15 cm H2O to 17.13 +/- 4.28 cm H2O; and the average value was 15.18% +/- 8.64% and 26.00% +/- 12.19% respectively (P < 0.01). But heart rate, blood pressure and FHVP were not altered after use of cimetidine ( P > 0.05). In the control group (n = 10), WHVP, HVPG, FHVP, heart rate, as well as blood pressure were not changed after placebo treatment. CONCLUSIONS: Both urapidil and cimetidine could reduce WHVP and HVPG significantly in cirrhotic patients with portal hypertension, and the effect of the two agents on WHVP and HVPG was not obviously different (P > 0.05). However, the systemic hemodynamic effects induced by urapidil were more significant compared with cimetidine.

Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil.[Pubmed:2569265]

Am J Cardiol. 1989 Aug 15;64(7):7D-10D.

Stimulation of serotonin-1A (5-hydroxytryptamine) (5-HT1A) receptors in the brain stem has been suggested to contribute to the antihypertensive action of the alpha 1-adrenoceptor antagonist urapidil. This hypothesis was tested by analyzing the influence of the 5-HT1A receptor antagonist spiroxatrine on the hypotensive responses to urapidil and the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT). Chloralose/urethane-anesthetized cats underwent thoracotomy and were artificially ventilated. Blood pressure was monitored in the femoral artery. Urapidil (0.01 to 10 mumol/kg) or 8-OH-DPAT (3 to 30 nmol/kg) was injected into a femoral vein and the maximal hypotensive response recorded. A dose-response test with both drugs was performed before and after administration of spiroxatrine (3 and 10 nmol/kg); the latter was given through the vertebral artery, thus delivering the antagonist to the brain stem. Blood pressure was dose-dependently reduced by urapidil and 8-OH-DPAT after intravenous injection. Central administration of spiroxatrine through the vertebral artery shifted the dose-response curves of both drugs markedly and in a dose-dependent manner to the right, while the hypotensive response to the peripheral vasodilator nitroglycerin remained unchanged. The results suggest that the hypotensive response after peripheral administration of urapidil is mediated in part by stimulation of brain 5-HT1A receptors and this effect on central cardiovascular regulation is additive to the blood pressure reduction resulting from peripheral alpha-adrenoceptor blockade.

Pharmacologic profile of urapidil.[Pubmed:2569262]

Am J Cardiol. 1989 Aug 15;64(7):1D-6D.

Urapidil, a phenylpiperazine-substituted derivative of uracil, is a selective alpha 1-adrenoceptor antagonist and therefore decreases blood pressure and peripheral resistance. Apart from its alpha 1-adrenoceptor-blocking potency, which is somewhat less selective than that of prazosin, urapidil appeared to display substantial central hypotensive activity. Initially, this central mechanism was assumed to be the same as that of clonidine, i.e., agonistic activity toward central alpha 2 adrenoceptors. This view, however, appeared to be incorrect for the following reasons: (1) In radioligand binding studies urapidil did not show any affinity for alpha 2 adrenoceptors; and (2) the central hypotensive activity of urapidil, injected into feline vertebral arteries remained unaffected by the alpha 2-adrenoceptor-blocking agents yohimbine and rauwolscine, which are known to suppress the central hypotensive effect of clonidine. The central hypotensive effect of urapidil so far remains unknown in detail, although a few (but not all) experimental arguments would plead for the 5-hydroxytryptamine (5-HT 1A)-agonistic potency of urapidil as an explanation of its central activity. The central hypotensive mechanism of urapidil will be discussed in more detail later in this issue. A presynaptic alpha 2-agonistic activity can only be demonstrated in certain models but not in the classic pithed rat preparation. It is unlikely to play a relevant role in urapidil's hypotensive activity, and also because of the poor affinity of the drug for alpha 2 adrenoceptors. Finally, a weak beta 1-adrenoceptor activity of urapidil can be demonstrated, but this mechanism is unlikely to contribute significantly to the drug's hypotensive activity.

Urapidil and some analogues with hypotensive properties show high affinities for 5-hydroxytryptamine (5-HT) binding sites of the 5-HT1A subtype and for alpha 1-adrenoceptor binding sites.[Pubmed:2832770]

Naunyn Schmiedebergs Arch Pharmacol. 1987 Dec;336(6):597-601.

The mechanism responsible for the antihypertensive effect of urapidil is not yet completely understood. Its vasodilator action has been attributed to an antagonism at vascular alpha 1-adrenoceptors. However, it has been suggested that a central action contributes to the hypotensive effect. Recently, three potent analogues of urapidil have been described which also lower blood pressure by a central mechanism. 5-Hydroxytryptamine (5-HT) receptors of the 5-HT1A subtype have been implicated with the central control of cardiovascular function. In the present study, the affinities of these urapidil derivatives (5-acetyl, 5-formyl- and 5-methyl-urapidil) for 5-HT receptors were investigated using 3H-8-hydroxy-2-(di-n-propyl-amino)tetralin (3H-8-OH-DPAT), 125I-iodocyanopindolol (125I-ICYP) and 3H-ketanserin for labelling 5-HT1A, 5-HT1B and 5-HT2 binding sites, respectively. 3H-Prazosin and 3H-clonidine were used as selective alpha 1- and alpha 2-adrenoceptor radioligands, respectively. Urapidil and its analogues produced half-maximum inhibition of 3H-8-OH-DPAT binding at concentrations of 4 x 10(-9) mol/l to 4 x 10(-7) mol/l with the following order of potency: urapidil less than 5-acetyl- less than or equal to 5-formyl- less than 5-methyl-urapidil. Thus, 5-methyl-urapidil is one of the most potent ligands at 5-HT1A recognition sites known to date. The IC50 values of urapidil and its derivatives for 3H-prazosin binding were in the range of 5 x 10(-8) mol/l to 8 x 10(-7) mol/l (order of potency: urapidil less than 5-formyl- less than 5-acetyl- less than 5-methyl-urapidil).(ABSTRACT TRUNCATED AT 250 WORDS)

Description

Urapidil HCl is an α1-adrenoceptor antagonist and 5-HT1A receptor agonist.

Keywords:

Urapidil HCl,64887-14-5,Natural Products,5-HT Receptor, buy Urapidil HCl , Urapidil HCl supplier , purchase Urapidil HCl , Urapidil HCl cost , Urapidil HCl manufacturer , order Urapidil HCl , high purity Urapidil HCl

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: